Page 16 - 775 News Today

The news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eigh...

Hospitalisations by death might have. , ., , ., have. the news of the efficacy of this particular — have. the news of the efficacy of this particular antiviral _ have. the news of the efficacy of this particular antiviral is - this particular antiviral is obviously particularly good news was at the company, when they briefed us last night had they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated elderly or medically at risk volu...

Approval by young people. i am joined by dr. peter hotez, he is also the dean at bail lor college of medicine. thank you for joining us. i want to ask you first, you know ive always been suspicious of vaccines or drugs when they come from drug companies particularly publicly traded drug companies and i like to hear this from experts like you. its got a drug. >> its a small study, its 775 individuals with covid, half who got the pills, half who did not, but there was a pretty striking reduction i...

Medication for covid—19. mark lobel reports. this is the first covid pill. trial results suggest it can cut hospitalisations or deaths by half. the news of the efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 unvaccinated, elderly or medically at risk volunteers within five days of them showing coronaviruse...

Is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given a placebo — or dummy pill ...

>> you got it right. will: you did? im impressed by myself. that drug, that drug apparently has a 50% reduction in hospitalizations when it comes to code. its oral, i believe, pill that you take. but what is interesting is studies out of harvard, for example, if i mentioned the drug that shall not be mentioned ivermectin that drug has reduced hospitalizations by as much as 80%. and that drug by the way is generic and not as much money to be made as prescribing ivermectin why this is a break thro...

Of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressive. pills were given to 775 elderly or medically at—risk patients within five days of them showing coronavirus symptoms. the data from a phase three trial showed 7.3% of patients on the drug were hospitalised, compared to 14.1% of those who did not take the tablets. eight patients who were given...

Pills twice a day. so you might take 40 pills or so. but it works in terms of reducing the hospitalizations by half. and in the control group, this was 775 patients with -- with sars 2 coronavirus. there were eight deaths in the control, and none in the treatment group. so its still not a huge study. but it was so compelling that the data safety monitoring board said, stop, we -- this -- this looks like its really promising, and i think on this basis, merck and company will file for emergency-us...

This is the first covid pill, trial results suggest taking cut hospitalisations or deaths by half. cut hospitalisations or deaths b half. , ., by half. the news of the efficacy _ by half. the news of the efficacy of _ by half. the news of the efficacy of this - by half. the news of the| efficacy of this particular antiviral is obviously very good news. the company, when they briefed us last night, had mentioned that they will be submitting their data to the fda imminently. the data are impressiv...

Announcing that trials show its new drug, molnupiravir, may cut the risk of hospitalization or death in half. >> this is a pill you can take at home and will significantly reduce the risk that you either ultimately are hospitalized or more importantly, that you would ever face the unfortunate outcome of death. >> reporter: the drug consists of 4 pills taken every 12 hours for 5 days, beginning soon after testing positive. the trial included 775 patients with mild to moderate covid who had at lea...